These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
385 related items for PubMed ID: 27296385
1. Protective Efficacy Induced by Genetically Attenuated Mid-to-Late Liver-Stage Arresting Plasmodium berghei Δmrp2 Parasites. van der Velden M, Rijpma SR, Verweij V, van Gemert GJ, Chevalley-Maurel S, van de Vegte-Bolmer M, Franke-Fayard BM, Russel FG, Janse CJ, Sauerwein RW, Koenderink JB. Am J Trop Med Hyg; 2016 Aug 03; 95(2):378-82. PubMed ID: 27296385 [Abstract] [Full Text] [Related]
2. Reduced Plasmodium berghei sporozoite liver load associates with low protective efficacy after intradermal immunization. Nganou-Makamdop K, Ploemen I, Behet M, Van Gemert GJ, Hermsen C, Roestenberg M, Sauerwein RW. Parasite Immunol; 2012 Dec 03; 34(12):562-9. PubMed ID: 23171040 [Abstract] [Full Text] [Related]
3. Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites. Butler NS, Schmidt NW, Vaughan AM, Aly AS, Kappe SH, Harty JT. Cell Host Microbe; 2011 Jun 16; 9(6):451-62. PubMed ID: 21669394 [Abstract] [Full Text] [Related]
4. A Sporozoite- and Liver Stage-expressed Tryptophan-rich Protein Plays an Auxiliary Role in Plasmodium Liver Stage Development and Is a Potential Vaccine Candidate. Jaijyan DK, Singh H, Singh AP. J Biol Chem; 2015 Aug 07; 290(32):19496-511. PubMed ID: 25960542 [Abstract] [Full Text] [Related]
5. A Plasmodium Parasite with Complete Late Liver Stage Arrest Protects against Preerythrocytic and Erythrocytic Stage Infection in Mice. Vaughan AM, Sack BK, Dankwa D, Minkah N, Nguyen T, Cardamone H, Kappe SHI. Infect Immun; 2018 May 07; 86(5):. PubMed ID: 29440367 [Abstract] [Full Text] [Related]
6. Assessing the adequacy of attenuation of genetically modified malaria parasite vaccine candidates. Annoura T, Ploemen IH, van Schaijk BC, Sajid M, Vos MW, van Gemert GJ, Chevalley-Maurel S, Franke-Fayard BM, Hermsen CC, Gego A, Franetich JF, Mazier D, Hoffman SL, Janse CJ, Sauerwein RW, Khan SM. Vaccine; 2012 Mar 30; 30(16):2662-70. PubMed ID: 22342550 [Abstract] [Full Text] [Related]
8. Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite. Friesen J, Matuschewski K. Vaccine; 2011 Sep 16; 29(40):7002-8. PubMed ID: 21787828 [Abstract] [Full Text] [Related]
9. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. Tarun AS, Dumpit RF, Camargo N, Labaied M, Liu P, Takagi A, Wang R, Kappe SH. J Infect Dis; 2007 Aug 15; 196(4):608-16. PubMed ID: 17624848 [Abstract] [Full Text] [Related]
10. Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection. Douradinha B, van Dijk MR, Ataide R, van Gemert GJ, Thompson J, Franetich JF, Mazier D, Luty AJ, Sauerwein R, Janse CJ, Waters AP, Mota MM. Int J Parasitol; 2007 Nov 15; 37(13):1511-9. PubMed ID: 17604034 [Abstract] [Full Text] [Related]
11. Defining rules of CD8(+) T cell expansion against pre-erythrocytic Plasmodium antigens in sporozoite-immunized mice. Billman ZP, Kas A, Stone BC, Murphy SC. Malar J; 2016 Apr 26; 15():238. PubMed ID: 27113469 [Abstract] [Full Text] [Related]
12. Importance of the Immunodominant CD8+ T Cell Epitope of Plasmodium berghei Circumsporozoite Protein in Parasite- and Vaccine-Induced Protection. Gibbins MP, Müller K, Glover M, Liu J, Putrianti ED, Bauza K, Reyes-Sandoval A, Matuschewski K, Silvie O, Hafalla JCR. Infect Immun; 2020 Sep 18; 88(10):. PubMed ID: 32719159 [Abstract] [Full Text] [Related]
13. Minimal role for the circumsporozoite protein in the induction of sterile immunity by vaccination with live rodent malaria sporozoites. Mauduit M, Tewari R, Depinay N, Kayibanda M, Lallemand E, Chavatte JM, Snounou G, Rénia L, Grüner AC. Infect Immun; 2010 May 18; 78(5):2182-8. PubMed ID: 20194600 [Abstract] [Full Text] [Related]
14. Cross-protection between attenuated Plasmodium berghei and P. yoelii sporozoites. Sedegah M, Weiss WW, Hoffman SL. Parasite Immunol; 2007 Nov 18; 29(11):559-65. PubMed ID: 17944745 [Abstract] [Full Text] [Related]
15. Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells. van Dijk MR, Douradinha B, Franke-Fayard B, Heussler V, van Dooren MW, van Schaijk B, van Gemert GJ, Sauerwein RW, Mota MM, Waters AP, Janse CJ. Proc Natl Acad Sci U S A; 2005 Aug 23; 102(34):12194-9. PubMed ID: 16103357 [Abstract] [Full Text] [Related]
16. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Mueller AK, Labaied M, Kappe SH, Matuschewski K. Nature; 2005 Jan 13; 433(7022):164-7. PubMed ID: 15580261 [Abstract] [Full Text] [Related]
17. Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells. Jobe O, Lumsden J, Mueller AK, Williams J, Silva-Rivera H, Kappe SH, Schwenk RJ, Matuschewski K, Krzych U. J Infect Dis; 2007 Aug 15; 196(4):599-607. PubMed ID: 17624847 [Abstract] [Full Text] [Related]
18. IL-12p40-independent induction of protective immunity upon multiple Plasmodium berghei irradiated sporozoite immunizations. Romero JF, Ibrahim GH, Renggli J, Himmelrich H, Graber P, Corradin G. Parasite Immunol; 2007 Nov 15; 29(11):541-8. PubMed ID: 17944743 [Abstract] [Full Text] [Related]
19. Long term protection after immunization with P. berghei sporozoites correlates with sustained IFNγ responses of hepatic CD8+ memory T cells. Nganou-Makamdop K, van Gemert GJ, Arens T, Hermsen CC, Sauerwein RW. PLoS One; 2012 Nov 15; 7(5):e36508. PubMed ID: 22563506 [Abstract] [Full Text] [Related]